Savant Capital LLC Has $2.99 Million Stock Holdings in SPDR S&P China ETF $GXC

Savant Capital LLC decreased its holdings in shares of SPDR S&P China ETF (NYSEARCA:GXC) by 3.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,123 shares of the company’s stock after selling 1,278 shares during the period. Savant Capital LLC owned 0.70% of SPDR S&P China ETF worth $2,988,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. CWM LLC lifted its stake in SPDR S&P China ETF by 423.4% in the first quarter. CWM LLC now owns 581 shares of the company’s stock valued at $50,000 after buying an additional 470 shares during the period. Optimum Investment Advisors lifted its position in shares of SPDR S&P China ETF by 45.0% during the 2nd quarter. Optimum Investment Advisors now owns 2,347 shares of the company’s stock valued at $205,000 after acquiring an additional 728 shares during the period. Worth Asset Management LLC acquired a new position in shares of SPDR S&P China ETF during the 2nd quarter valued at $220,000. Clark Capital Management Group Inc. bought a new position in SPDR S&P China ETF during the first quarter worth $288,000. Finally, Jones Financial Companies Lllp grew its holdings in SPDR S&P China ETF by 4,448.1% in the first quarter. Jones Financial Companies Lllp now owns 3,593 shares of the company’s stock worth $309,000 after purchasing an additional 3,514 shares during the period.

SPDR S&P China ETF Trading Up 1.5%

Shares of NYSEARCA GXC opened at $103.66 on Tuesday. The firm has a market capitalization of $497.57 million, a P/E ratio of 12.97 and a beta of 0.28. The firm’s 50-day moving average price is $102.39 and its 200-day moving average price is $93.77. SPDR S&P China ETF has a 1-year low of $70.92 and a 1-year high of $107.01.

SPDR S&P China ETF Company Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.